Glioblastoma is one of the most dangerous tumors for patients in clinical practice at present, and since glioblastoma originates from the brain, it will have a serious impact on patients. Therefore, more effective clinical therapeutic targets are still needed at this stage. Kinesin family member 15 (KIF15) promotes proliferation in several cancers, but its effect on glioblastoma is unclear. In this study, differentially expressed gene analysis and network analysis were performed to identify critical genes affecting glioma progression. The samples were divided into a KIF15 high-expression group and KIF15 low-expression group, and the association between FIK15 expression level and clinical characteristics was summarized and analyzed by performing medical data analysis; the effect of KIF15 on glioblastoma cell proliferation was detected by employing colony formation and MTT assays. The effect of KIF15 on tumor growth in mice was determined. It was found that KIF15 was a potential gene affecting the progression of glioblastoma. In addition, KIF15 was highly expressed in glioblastoma tumor tissues, and KIF15 was correlated with tumor size, clinical stage and other clinical characteristics. After the KIF15 gene was knocked out, the proliferation ability of glioblastoma was significantly inhibited. KIF15 also contributed to the growth of glioblastoma tumors in mice. Therefore, we found KIF15 to be a promising clinical therapeutic target.
Citation: Leibo Wang, Xuebin Zhang, Jun Liu, Qingjun Liu. RETRACTED ARTICLE: Kinesin family member 15 can promote the proliferation of glioblastoma[J]. Mathematical Biosciences and Engineering, 2022, 19(8): 8259-8272. doi: 10.3934/mbe.2022384
| [1] | Editorial Office of Mathematical Biosciences and Engineering . Retraction notice to "Kinesin family member 15 can promote the proliferation of glioblastoma" [Mathematical Biosciences and Engineering 19(8) (2022) 8259–8272]. Mathematical Biosciences and Engineering, 2024, 21(4): 5686-5686. doi: 10.3934/mbe.2024250 |
| [2] | Tracy L. Stepien, Erica M. Rutter, Yang Kuang . A data-motivated density-dependent diffusion model of in vitro glioblastoma growth. Mathematical Biosciences and Engineering, 2015, 12(6): 1157-1172. doi: 10.3934/mbe.2015.12.1157 |
| [3] | Giulia Pozzi, Stefano Marchesi, Giorgio Scita, Davide Ambrosi, Pasquale Ciarletta . Mechano-biological model of glioblastoma cells in response to osmotic stress. Mathematical Biosciences and Engineering, 2019, 16(4): 2795-2810. doi: 10.3934/mbe.2019139 |
| [4] | Yuan Yang, Yuwei Ye, Min Liu, Ya Zheng, Guozhi Wu, Zhaofeng Chen, Yuping Wang, Qinghong Guo, Rui Ji, Yongning Zhou . Family with sequence similarity 153 member B as a potential prognostic biomarker of gastric cancer. Mathematical Biosciences and Engineering, 2022, 19(12): 12581-12600. doi: 10.3934/mbe.2022587 |
| [5] | Melanie A. Jensen, Qingzhou Feng, William O. Hancock, Scott A. McKinley . A change point analysis protocol for comparing intracellular transport by different molecular motor combinations. Mathematical Biosciences and Engineering, 2021, 18(6): 8962-8996. doi: 10.3934/mbe.2021442 |
| [6] | Ardak Kashkynbayev, Yerlan Amanbek, Bibinur Shupeyeva, Yang Kuang . Existence of traveling wave solutions to data-driven glioblastoma multiforme growth models with density-dependent diffusion. Mathematical Biosciences and Engineering, 2020, 17(6): 7234-7247. doi: 10.3934/mbe.2020371 |
| [7] | Duane C. Harris, Giancarlo Mignucci-Jiménez, Yuan Xu, Steffen E. Eikenberry, C. Chad Quarles, Mark C. Preul, Yang Kuang, Eric J. Kostelich . Tracking glioblastoma progression after initial resection with minimal reaction-diffusion models. Mathematical Biosciences and Engineering, 2022, 19(6): 5446-5481. doi: 10.3934/mbe.2022256 |
| [8] | Tiberiu Harko, Man Kwong Mak . Travelling wave solutions of the reaction-diffusion mathematical model of glioblastoma growth: An Abel equation based approach. Mathematical Biosciences and Engineering, 2015, 12(1): 41-69. doi: 10.3934/mbe.2015.12.41 |
| [9] | Lifeng Han, Steffen Eikenberry, Changhan He, Lauren Johnson, Mark C. Preul, Eric J. Kostelich, Yang Kuang . Patient-specific parameter estimates of glioblastoma multiforme growth dynamics from a model with explicit birth and death rates. Mathematical Biosciences and Engineering, 2019, 16(5): 5307-5323. doi: 10.3934/mbe.2019265 |
| [10] | Shequn Gu, Jihui Luo, Wenxiu Yao . The regulation of miR-139-5p on the biological characteristics of breast cancer cells by targeting COL11A1. Mathematical Biosciences and Engineering, 2020, 17(2): 1428-1441. doi: 10.3934/mbe.2020073 |
Glioblastoma is one of the most dangerous tumors for patients in clinical practice at present, and since glioblastoma originates from the brain, it will have a serious impact on patients. Therefore, more effective clinical therapeutic targets are still needed at this stage. Kinesin family member 15 (KIF15) promotes proliferation in several cancers, but its effect on glioblastoma is unclear. In this study, differentially expressed gene analysis and network analysis were performed to identify critical genes affecting glioma progression. The samples were divided into a KIF15 high-expression group and KIF15 low-expression group, and the association between FIK15 expression level and clinical characteristics was summarized and analyzed by performing medical data analysis; the effect of KIF15 on glioblastoma cell proliferation was detected by employing colony formation and MTT assays. The effect of KIF15 on tumor growth in mice was determined. It was found that KIF15 was a potential gene affecting the progression of glioblastoma. In addition, KIF15 was highly expressed in glioblastoma tumor tissues, and KIF15 was correlated with tumor size, clinical stage and other clinical characteristics. After the KIF15 gene was knocked out, the proliferation ability of glioblastoma was significantly inhibited. KIF15 also contributed to the growth of glioblastoma tumors in mice. Therefore, we found KIF15 to be a promising clinical therapeutic target.
| [1] |
X. X. Ke, Y. Pang, K. Chen, D. Zhang, F. Wang, S. Zhu, et al., Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway, Oncol. Rep., 40 (2018), 3313-3322. https://doi.org/10.3892/or.2018.6777 doi: 10.3892/or.2018.6777
|
| [2] |
H. Y. Li, B. B. Lv, Y. H. Bi, FABP4 accelerates glioblastoma cell growth and metastasis through Wnt10b signalling, Eur. Rev. Med. Pharmacol. Sci., 22 (2018), 7807-7818. https://doi.org/10.26355/eurrev_201811_16405 doi: 10.26355/eurrev_201811_16405
|
| [3] |
T. Mashimo, K. Pichumani, V. Vemireddy, K. J. Hatanpaa, D. K. Singh, S. Sirasanagandla, et al., Acetate is a bioenergetic substrate for human glioblastoma and brain metastases, Cell, 159 (2014), 1603-1614. https://doi.org/10.1016/j.cell.2014.11.025 doi: 10.1016/j.cell.2014.11.025
|
| [4] |
A. Vartanian, S. Agnihotri, M. R. Wilson, K. E. Burrell, P. D. Tonge, A. Alamsahebpour, et al., Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma, Oncotarget, 7 (2016), 69518-69535. https://doi.org/10.18632/oncotarget.11680 doi: 10.18632/oncotarget.11680
|
| [5] |
B. Huang, T. A. Dolecek, Q. Chen, C. R. Garcia, T. Pittman, J. L. Villano, Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma, Med. Oncol., 35 (2018), 74. https://doi.org/10.1007/s12032-018-1134-3 doi: 10.1007/s12032-018-1134-3
|
| [6] |
Z. Shboul, L. Vidyaratne, M. Alam, S. M. S. Reza, K. M. Iftekharuddin, Glioblastoma and survival prediction, Lect. Notes Comput. Sci., 10670 (2018), 358-368. https://doi.org/10.1007/978-3-319-75238-9_31 doi: 10.1007/978-3-319-75238-9_31
|
| [7] |
J. K. Sa, S. H. Kim, J. K. Lee, H. J. Cho, Y. J. Shin, H. Shin, et al., Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma, Neuro-oncology, 21 (2019), 222-233. https://doi.org/10.1093/neuonc/noy105 doi: 10.1093/neuonc/noy105
|
| [8] |
Z. C. Zhu, J. W. Liu, K. Li, J. Zheng, Z. Q. Xiong, KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells, Oncogene, 37 (2018), 2936-2952. https://doi.org/10.1038/s41388-018-0180-9 doi: 10.1038/s41388-018-0180-9
|
| [9] |
M. Westphal, C. L. Maire, K. Lamszus, EGFR as a target for glioblastoma treatment: An unfulfilled promise, CNS Drugs, 31 (2017), 723-735. https://doi.org/10.1007/s40263-017-0456-6 doi: 10.1007/s40263-017-0456-6
|
| [10] |
N. Hirokawa, Y, Tanaka, Kinesin superfamily proteins (KIFs): Various functions and their relevance for important phenomena in life and diseases, Exp. Cell Res., 334 (2015), 16-25. https://doi.org/10.1016/j.yexcr.2015.02.016 doi: 10.1016/j.yexcr.2015.02.016
|
| [11] | N. Hirokawa, From electron microscopy to molecular cell biology, molecular genetics and structural biology: Intracellular transport and kinesin superfamily proteins, KIFs: Genes, structure, dynamics and functions, J. Electron Microsc., 60 (2011), 63-92. https://doi.org/10.1093/jmicro/dfr051 |
| [12] |
S. S. Siddiqui, Metazoan motor models: Kinesin superfamily in C. elegans, Traffic, 3 (2002), 20-28. https://doi.org/10.1034/j.1600-0854.2002.30104.x doi: 10.1034/j.1600-0854.2002.30104.x
|
| [13] |
H. Miki, M. Setou, K. Kaneshiro, N. Hirokawa, All kinesin superfamily protein, KIF, genes in mouse and human, Proc. Natl. Acad. Sci. U.S.A., 98 (2001), 7004-7011. https://doi.org/10.1073/pnas.111145398 doi: 10.1073/pnas.111145398
|
| [14] |
Y. M. Lee, W. Kim, Kinesin superfamily protein member 4 (KIF4) is localized to midzone and midbody in dividing cells, Exp. Mol. Med., 36 (2004), 93-97. https://doi.org/10.1038/emm.2004.13 doi: 10.1038/emm.2004.13
|
| [15] |
Z. Shen, A. R. Collatos, J. P. Bibeau, F. Furt, L. Vidali, Phylogenetic analysis of the Kinesin superfamily from physcomitrella, Front. Plant Sci., 3 (2012), 230. https://doi.org/10.3389/fpls.2012.00230 doi: 10.3389/fpls.2012.00230
|
| [16] |
K. Tang, N. H. Toda, A microtubule polymerase cooperates with the kinesin-6 motor and a microtubule cross-linker to promote bipolar spindle assembly in the absence of kinesin-5 and kinesin-14 in fission yeast, Mol. Biol. Cell, 28 (2017), 3647-3659. https://doi.org/10.1091/mbc.e17-08-0497 doi: 10.1091/mbc.e17-08-0497
|
| [17] |
T. McHugh, H. Drechsler, A. D. McAinsh, N. J. Carter, R. A. Cross, Kif15 functions as an active mechanical ratchet, Mol. Biol. Cell, 29 (2018), 1743-1752. https://doi.org/10.1091/mbc.E18-03-0151 doi: 10.1091/mbc.E18-03-0151
|
| [18] |
M. Xu, D. Liu, Z. Dong, X. Wang, X. Wang, Y. Liu, et al., Kinesin-12 influences axonal growth during zebrafish neural development, Cytoskeleton, 71 (2014), 555-563. https://doi.org/10.1002/cm.21193 doi: 10.1002/cm.21193
|
| [19] |
J. Feng, Z. Hu, H. Chen, J. Hua, R. Wu, Z. Dong, et al., Depletion of kinesin-12, a myosin-ⅡB-interacting protein, promotes migration of cortical astrocytes, J. Cell. Sci., 129 (2016), 2438-2447. https://doi.org/10.1242/jcs.181867 doi: 10.1242/jcs.181867
|
| [20] |
H. Miki, M. Setou, K. Kaneshiro, N. Hirokawa, All kinesin superfamily protein, KIF, genes in mouse and human, Proc. Natl. Acad. Sci. U.S.A., 98 (2001), 7004-7011. https://doi.org/10.1073/pnas.111145398 doi: 10.1073/pnas.111145398
|
| [21] |
J. Wang, X. Guo, C. Xie, J. Jiang, KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway, Br. J. Cancer, 117 (2017), 245-255. https://doi.org/10.1038/bjc.2017.165 doi: 10.1038/bjc.2017.165
|
| [22] |
Y. Qiao, J. Chen, C. Ma, Y. Liu, P. Li, Y. Wang, et al., Increased KIF15 expression predicts a poor prognosis in patients with lung adenocarcinoma, Cell Physiol. Biochem., 51 (2018), 1-10. https://doi.org/10.1159/000495155 doi: 10.1159/000495155
|
| [23] |
G. Harris, D. Jayamanne, H. Wheeler, C. Gzell, M. Kastelan, G. Schembri, et al., Survival Outcomes of Elderly Patients With glioblastoma multiforme in their 75th year or older treated with adjuvant therapy, Int. J. Radiat. Oncol. Biol. Phys., 98 (2017), 802-810. https://doi.org/10.1016/j.ijrobp.2017.02.028 doi: 10.1016/j.ijrobp.2017.02.028
|
| [24] |
K. K. Jain, A critical overview of targeted therapies for glioblastoma, Front. Oncol., 8 (2018), 419. https://doi.org/10.3389/fonc.2018.00419 doi: 10.3389/fonc.2018.00419
|
| [25] |
Y. Zheng, N. Gao, Y. L. Fu, B. Y. Zhang, X. L. Li, P. Gupta, et al., Generation of regulable EGFRvⅢ targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma, Biochem. Biophys. Res. Commun., 507 (2018), 59-66. https://doi.org/10.1016/j.bbrc.2018.10.151 doi: 10.1016/j.bbrc.2018.10.151
|
| [26] |
M. Momeny, F. Moghaddaskho, N. K. Gortany, H. Yousefi, Z. Sabourinejad, G. Zarrinrad, et al., Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells, Sci. Rep., 7 (2017), 44075. https://doi.org/10.1038/srep44075 doi: 10.1038/srep44075
|
| [27] |
E. G. Sturgill, S. R. Norris, Y. Guo, R. Ohi, Kinesin-5 inhibitor resistance is driven by kinesin-12, J. Cell. Biol., 213 (2016), 213-227. https://doi.org/10.1083/jcb.201507036 doi: 10.1083/jcb.201507036
|
| [28] |
C. Müller, D. Gross, V. Sarli, M. Gartner, A. Giannis, G. Bernhardt, et al., Inhibitors of kinesin Eg5: Antiproliferative activity of monastrol analogues against human glioblastoma cells, Cancer Chemother. Pharmacol., 59 (2007), 157-164. https://doi.org/10.1007/s00280-006-0254-1 doi: 10.1007/s00280-006-0254-1
|
| [29] |
A. I. Marcus, U. Peters, S. L. Thomas, S. Garrett, A. Zelnak, T. M. Kapoor, et al., Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and sensitive cancer cells, J. Biol. Chem., 280 (2005), 11569-11577. https://doi.org/10.1074/jbc.M413471200 doi: 10.1074/jbc.M413471200
|
| [30] |
D. W. Buster, D. H. Baird, W. Yu, J. M. Solowska, M. Chauviere, A. Mazurek, Expression of the mitotic kinesin Kif15 in postmitotic neurons: Implications for neuronal migration and development, J. Neurocytol., 32 (2003), 79-96. https://doi.org/10.1023/A:1027332432740 doi: 10.1023/A:1027332432740
|
| [31] |
B. Stangeland, A. A. Mughal, Z. Grieg, C. J. Sandberg, M. Joel, S. Nygard, et al., Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells, Oncotarget, 6 (2015), 26192-26215. https://doi.org/10.18632/oncotarget.4613 doi: 10.18632/oncotarget.4613
|
| [32] |
O. Rath, F. Kozielski, Kinesins and cancer, Nat. Rev. Cancer, 12 (2012), 527-539. https://doi.org/10.1038/nrc3310 doi: 10.1038/nrc3310
|
| [33] |
G. Bergnes, K. Brejc, L. Belmont, Mitotic kinesins: Prospects for antimitotic drug discovery, Curr. Top. Med. Chem., 5 (2005), 127-145. https://doi.org/10.2174/1568026053507697 doi: 10.2174/1568026053507697
|
| [34] |
Z. Z. Wang, J. Yang, B. H. Jiang, J. B. Di, P. Gao, L. Peng, et al., KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer, Int. J. Oncol., 53 (2018), 1939-1952. https://doi.org/10.3892/ijo.2018.4546 doi: 10.3892/ijo.2018.4546
|
| [35] |
X. Zhao, L. L. Zhou, X. Li, J. Ni, P. Chen, R. Ma, Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis, Cancer Med., 7 (2018), 4678-4689. https://doi.org/10.1002/cam4.1710 doi: 10.1002/cam4.1710
|
| [36] |
Y. Teng, B. Guo, X. Mu, S. Liu, KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer, Biomed. Pharmacother., 108 (2018), 766-773. https://doi.org/10.1016/j.biopha.2018.09.036 doi: 10.1016/j.biopha.2018.09.036
|
| [37] |
Q. Y. Wang, B. Han, W. Huang, C. J. Qi, F. Liu, Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma, Oncol. Rep., 43 (2020), 1035-1044. https://doi.org/10.3892/or.2020.7510 doi: 10.3892/or.2020.7510
|
| 1. | Retraction notice to "Kinesin family member 15 can promote the proliferation of glioblastoma" [Mathematical Biosciences and Engineering 19(8) (2022) 8259–8272], 2024, 21, 1551-0018, 5686, 10.3934/mbe.2024250 | |
| 2. | Yan-Xuan Yin, Meng-Qi Ding, Yang Yi, Yuan-Jing Zou, Bi-Yun Liao, Shao-Chen Sun, Insufficient KIF15 during porcine oocyte ageing induces HDAC6-based microtubule instability, 2024, 226, 0093691X, 49, 10.1016/j.theriogenology.2024.05.043 | |
| 3. | Poh-Shiow Yeh, Chien-Te Liu, Chia-Ying Yu, Ya-Chuan Chang, Shu-Yu Lin, Yun-Chen Li, Yu-Ze Luan, Wen-Wei Sung, Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme, 2024, 15, 1663-9812, 10.3389/fphar.2024.1419044 |
Leibo Wang, Xuebin Zhang, Jun Liu, Qingjun Liu. RETRACTED ARTICLE: Kinesin family member 15 can promote the proliferation of glioblastoma[J]. Mathematical Biosciences and Engineering, 2022, 19(8): 8259-8272. doi: 10.3934/mbe.2022384
DownLoad: